¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"toxic effect curve"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • curve
    °î¼±
  • calibration curve
    ±³Á¤°î¼±, Ç¥ÁØÈ­°î¼±
  • demand curve
    ¼ö¿ä°î¼±
  • depth dose curve
    ½ÉºÎ¼±·®°î¼±
  • dissociation curve
    ÇØ¸®°î¼±
  • distribution curve
    ºÐÆ÷°î¼±
  • dose-response curve
    ¿ë·®¹ÝÀÀ°î¼±
  • extension curve
    ½ÅÀü°î¼±
  • elastic curve
    ź·Â°î¼±
  • epidemic curve
    À¯Çà°î¼±
  • equal loudness curve
    À½·®µî°¨°î¼±
  • equilibrium curve
    ÆòÇü°î¼±
  • flow volume curve
    À¯·®¿ë·®°î¼±
  • fluid velocity curve
    À¯¼Ó°î¼±
  • frequency curve
    µµ¼ö°î¼±
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inhibitory effect
    ¾ïÁ¦È¿°ú
  • palliative effect
    ¿ÏÈ­È¿°ú, °æ°¨È¿°ú
  • prolonged effect
    Áö¼ÓÈ¿°ú
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • reversing effect
    ¿ªÀüÈ¿°ú
  • shielding effect
    Â÷ÆóÈ¿°ú, °¡¸²È¿°ú
  • stochastic effect
    È®·ü·ÐÀûÈ¿°ú
  • synergistic effect
    »ó½ÂÈ¿°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • toxic dose
    Áßµ¶¿ë·®, Áßµ¶·®, µ¶¼º¿ë·®, µ¶¼º·®
  • toxic dyspepsia
    Áßµ¶¼ÒÈ­ºÒ·®
  • toxic edema
    Áßµ¶ºÎÁ¾
  • toxic effluvium
    µ¶¼ºÅ»¸ð
  • toxic erythema
    Áßµ¶È«¹Ý
  • toxic gastritis
    Áßµ¶À§¿°
  • toxic glycosuria
    Áßµ¶´ç´¢
  • toxic granule
    µ¶¼º°ú¸³
  • toxic hepatitis
    µ¶¼º°£¿°
  • toxic injury
    µ¶¼º¼Õ»ó
  • toxic leukocytosis
    Áßµ¶¹éÇ÷±¸Áõ°¡Áõ
  • toxic megacolon
    µ¶¼ºÅ«°áÀåÁõ
  • naturally toxic plant
    ÀÚ¿¬µ¶¼º½Ä¹°
  • toxic nephropathy
    µ¶¼ÒÄáÆÏº´Áõ
  • toxic nephrosis
    µ¶¼ºÄáÆÏÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intensity duration curve
    °­µµ±â°£°î¼±
  • phase curve
    À§»ó °î¼±
  • plane curve
    Æò¸é°î¼±(øÁØüÍØàÊ).
  • preponderance curve
    ¿ì¼¼°î¼±(¡­ÍØàÊ).
  • pressure volume curve
    ¾Ð·Â¿ëÀû°î¼±(äâæ³é»îÝÍØàÊ).
  • probability curve
    È®·ü°î¼±(ÊÙË­ËÛ).
  • pulse curve =sphymogram
    ¸Æ¹Ú°î¼±(ØæÚÑÍØàÊ).
  • quadratic curve
    ÀÌÂ÷°î¼±(ì£ó­ÍØàÊ).
  • regression curve
    ȸ±Í°î¼±(Ì·Ë´Ë­ËÛ).
  • Bernouilli effect
    º£¸£´©ÀÌ È¿°ú
  • Bohr effect
    º¸¾Æ È¿°ú(üùÍý)
  • CPE=£¾cytopathogenic effect
    ¼¼Æ÷º´º¯È¿°ú.
  • CPE=£¾cytopathogenic effect
    ¼¼Æ÷º´º¯È¿°ú.
  • Cytopath(ogen)ic effect, CPE
    ¼¼Æ÷º´º¯È¿°ú
  • Donnan effect
    µ·³­È¿°ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • syndrome, toxic shock
    µ¶¼º¼îÅ© ÁõÈıº
  • toxemic vertigo =toxic v.
    Áßµ¶¼º¾îÁö·³
  • toxic
    µ¶¼ºÀÇ
  • toxic
    µ¶¼ºÀÇ.
  • toxic (liver) cirrhosis
    Áßµ¶¼º°£°æº¯(Áõ)(ñéÔ¸ àõÊÜÌãܨñø)
  • toxic action
    µ¶ÀÛ¿ë(Ô¸íÂéÄ).
  • toxic agent
    µ¶¹°.
  • toxic alopecia
    µ¶¼º Å»¸ð(Áõ)
  • toxic amaurosis
    Áßµ¶¼ºÈæ³»Àå(¡­ýÙÒ®íô)
  • toxic amblyopia
    Áßµ¶¾à½Ã(¡­å°ãÊ).
  • toxic anemia
    Áßµ¶¼ººóÇ÷(ñéÔ¸àõÞ¸úì)
  • toxic asthma
    Áßµ¶¼ºÃµ½Ä(ñéÔ¸àõô·ãÓ)
  • toxic atrophy
    Áßµ¶¼ºÀ§Ãà(ñéÔ¸àõê×õê)
  • toxic cardiopathy
    Áßµ¶¼º½ÉÀ庴Áõ
  • toxic cataract
    Áßµ¶¹é³»Àå(¡­ÛÜÒ®î¡).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • polarization curve
    Æí±Ø°î¼±(ø¶Ð¿ÍØàÊ)
  • precipitin curve
    ħ°­¼Ò(öØË½áÈ) °î¼±(ÍØàÊ)
  • probability curve
    È®·ü °î¼±(ü¬×ËÍØàÊ)
  • progress curve
    ÁøÇà°î¼±(òäú¼ÍØàÊ)
  • quench correction curve
    ¼Ò±¤ ±³Á¤°î¼±(á¼ÎÃÎìïáÍØàÊ).
  • regression curve
    ȸ±Í°î¼±(üÞÏýÍØàÊ)
  • saturation curve
    Æ÷È­ °î¼±(øéûùÍØàÊ)
  • solubility curve
    ¿ëÇØµµ °î¼±(éÁú°ÓøÍØàÊ)
  • S-shaped curve
    SÀÚ(í®)Çü(úþ) °î¼±(ÍØàÊ)
  • standard curve
    Ç¥Áذ(øöñÞÍØàÊ)
  • survival curve
    »ýÁ¸°î¼± (ßæðíÍØàÊ)
  • titration curve
    ÀûÁ¤ °î¼± (îÙïÒÍØàÊ)
  • anomeric effect
    ¾Æ³ë¸Ó¿µÇâ(ç¯úÂ)
  • asymmetry effect
    ºÎÀçÈ¿°ú(Üôî²üùÍý)
  • Blinks effect
    ºí¸°Å©½º È¿°ú(üùÍý) (ÔÒ) chromatic transient
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Bernouilli effect
    º£¸£´©ÀÌÈ¿°ú
  • biologic effect
    »ý¹°ÇÐÀûÈ¿°ú
  • biological effect
    »ý¹°ÇÐÀûÈ¿°ú
  • cavitation effect
    °øµ¿È¿°ú
  • direct piezoelectric effect
    Á÷Á¢¾ÐÀüÈ¿°ú
  • Doppler effect
    µµÇ÷¯È¿°ú
  • effect
    È¿°ú, ÀÛ¿ë
  • entry slice effect
    À¯ÀԴܸéÈ¿°ú
  • fast scan effect
    °í¼Ó½ºÄµÈ¿°ú
  • Gibbs effect
    ±é½º È¿°ú
  • gradient echo effect
    °æ»ç¿¡ÄÚÈ¿°ú
  • gradient induced phase shift effect
    °æ»çÀ¯µµ À§»óº¯À§È¿°ú
  • halo effect
    ´Þ¹«¸®È¿°ú
  • immediate effect
    Áﰢȿ°ú, Áï½ÃÈ¿°ú
  • in-flow effect
    À¯ÀÔ È¿°ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CPC central posterior curve; cerebellar Purkinje cell; cerebral palsy clinic; cerebral performance categ...
EFVC expiratory flow-volume curve
H&D Hunter and Driffield [curve]
IRC inspiratory reserve capacity; instantaneous resonance curve; International Red Cross; International ...
IVPF isovolume pressure flow curve
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TEQ Toxic Equivalents
TOS Toxic Oil Syndrome
TRI Toxic Release Inventory
TSS Toxic Shock Syndrome
TSST-1 Toxic Shock Syndrome Toxin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • area under the concentration-time curve
    Ç÷Áß ³óµµ °î¼±ÇÏ ¸éÀû, Ç÷Áß ¾à¹° ³óµµ °î¼±ÇÏ ¸éÀû
  • auditory sensation curve
    °¡Ã» °î¼±
  • Barnes' curve
    ¹Ù¾È½º °î¼±
    õ°ñ°©°¢À» Áß½ÉÀ¸·Î ÇÏ´Â °î¼±.
  • calibration curve
    º¸Á¤ °î¼±, Ç¥ÁØÈ­ °î¼±
  • carbon dioxide dissociation curve
    ź»ê °¡½º ÇØ¸® °î¼±
  • cell survival curve
    ¼¼Æ÷ »ýÁ¸ °î¼±
  • compensating curve
    Á¶Àý ¸¸°î
    »ó¾Ç Ä¡¿­¿¡ À־ ¼Ò±¸Ä¡ ´ë±¸Ä¡ÀÇ ÇùÃø ±³µÎ¸éÀ» ¿¬°áÇϸé, ¾Æ·¡·Î º¼·ÏÇÑ °î¼±À» ±×¸®°í ÀÖ´Ù. ÀÌ ¸¸°î¿¡ ÀÇÇÏ¿© ÇϾÇÀÇ Ãø¹æ ¿îµ¿ ½Ã¿¡ °úµÎ°¡ ÀüÇϹæÀ¸·Î ¿îµ¿ÇÏ´õ¶óµµ »óÇÏ Ä¡¾ÆÀÇ ±ÕÇü Á¢ÃËÀº À¯ÁöµÇµµ·Ï Á¶ÀýµÈ´Ù. °¡·É »óÇÏÀÇ Ä¡¾Æ°¡ Æò¸é»ó¿¡ ¹è¿­Çß´Ù°í ÇÑ´Ù¸é, Ãø¹æ ¿îµ¿¿¡ ÀÇÇÏ¿© °úµÎ´Â »ç¸é¿¡ µû¶ó ÀüÇϹæÀ¸·Î À̵¿ÇϹǷÎ, ´ë±¸Ä¡ ¹× ¼Ò±¸Ä¡¿¡¼­ »óÇÏ Ä¡¾Æ »çÀÌ¿¡ Æ´ÀÌ »ý±ä´Ù. À̰ÍÀ» ÆòźÇÑ Ä¡¾ÆÀÇ ¿îµ¿°ú ºñ½ºµëÇÑ ±³µÎÀÇ ¿îµ¿¸é°úÀÇ »çÀÌ¿¡ ºÒ±ÕÇüÀÌ »ý±â±â ¶§¹®ÀÌ´Ù. ±×·¯¹Ç·Î ¸¸°î¸é »ó¿¡ Ä¡¾Æ¸¦ ¹è¿­ÇÑ´Ù. ÀÌ ¿ë¾î´Â ÀÇÄ¡¿¡ ÇÑÇÏ¿© »ç¿ëµÇ´Â °æ¿ì°¡ ¸¹´Ù.
  • concentration-response curve
    ³óµµ ¹ÝÀÀ °î¼±
  • curve of dental cervical line
    Ä¡°æ ¼± ¸¸°î
  • curve of occlusion
    ±³ÇÕ ¸¸°î
    ÇöÁ¸ÇÏ´Â Ä¡¾ÆÀÇ Àý´Ü°ú ±³µÎÀÇ ´ëºÎºÐÀÌ µ¿½Ã¿¡ Á¢ÃËµÇ¸é ¸¸°î ¼±À¸·Î ¸éÀ» ÀÌ·ç´Âµ¥ À̸¦ ±³ÇÕ ¸¸°îÀ̶ó ÇÑ´Ù.
  • curve of Spee
    ½ºÇÇ ¸¸°î
    ÇÏ¾Ç ÀüÄ¡ÀÇ ±³µÎÁ¤¿¡¼­ ½ÃÀÛÇØ¼­ ¼Ò±¸Ä¡¿Í ´ë±¸Ä¡ÀÇ ÇùÃø ±³µÎÁ¤À» ¿¬°ÉÇÑ ¸¸°îÀ¸·Î ½Ã»ó ¸é¿¡¼­ °üÂûÇÒ ¼ö ÀÖ´Â ÀüÈÄ ¸¸°îÀÌ´Ù.
  • curve symbol
    ¸¸°î ¡ÈÄ
  • dose-response curve
    ¿ë·® ¹ÝÀÀ °î¼±
  • equal loudness curve
    À½·® µî°¨ °î¼±
  • equidistant curve
    µî°Å¸® °î¼±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
toxic cataract A cataract caused by drugs or chemicals.
(05 Mar 2000)
toxic cirrhosis Cirrhosis of the liver resulting from chronic poisoning, as by lead or carbon tetrachloride.
(05 Mar 2000)
toxic cyanosis Cyanosis due to methemoglobin formation resulting from the action of certain drugs, e.g., nitrites.
(05 Mar 2000)
toxic delirium Delirium caused by the action of a poison.
(05 Mar 2000)
toxic epidermal necrolysis A syndrome in which a large portion of the skin becomes intensely erythematous with epidermal necrosis, and peels off in the manner of a second-degree burn, often simultaneous with the formation of flaccid bullae, resulting from drug sensitivity or of unknown cause; the level of separation is subepidermal, unlike staphylococcal scalded skin syndrome in which there is subcorneal change.
Synonym: Lyell's syndrome.
(05 Mar 2000)
toxic equivalent The amount of toxin or other poison per kilogram of body weight necessary to kill an animal.
(05 Mar 2000)
toxic goiter A goiter that forms an excessive secretion, causing signs and symptoms of hyperthyroidism.
(05 Mar 2000)
toxic haemoglobinuria Haemoglobinuria occurring after the ingestion of various poisons, in certain blood diseases, and in certain infections.
(05 Mar 2000)
toxic hydrocephalus Thrombotic hydrocephalus associated with some general infection or toxic state.
(05 Mar 2000)
toxic megacolon <gastroenterology, surgery> An acute nonobstructive dilation of the colon, seen in advanced ulcerative colitis and Crohn's disease.
(12 Jan 1998)
toxic multinodular goiter Condition in which the thyroid gland contains multiple lumps (nodules) that are overactive, produce excess thyroid hormones and thereby cause hyperthyroidism. This condition is also known as parry's disease or plummer's disease.
(12 Dec 1998)
toxic nephrosis Acute oliguric renal failure due to chemical poisons, septicaemia, or bacterial toxaemia; frequently associated with extensive necrosis of proximal convoluted tubules.
(05 Mar 2000)
toxic neuritis Neuritis caused by an endogenous or exogenous toxin.
(05 Mar 2000)
toxic nodular goitre <endocrinology> An enlarged thyroid gland which contains nodules which release excess thyroid hormone. This condition usually arises from long-standing simple goitre in the elderly.
Symptoms of hyperthyroidism result.
(12 Jan 1998)
toxic psychosis A psychosis caused by some toxic substance, whether endogenous or exogenous.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Compton effect
    ÄÞÇÁÅÏ È¿°ú(±¤ÀÚ¿Í ÀüÀÚÀÇ Åº¼º »ê¶õ)
  • Donald Duck effect
    µµ³Îµå ´ö È¿°ú(¿ìÁÖ ºñÇàÁßÀÇ À½¼ºÀÇ °íÀ½È­ Çö»ó)
  • Doppler effect
    µµÇ÷¯ È¿°ú 
  • Gunn effect
    ¿µ±¹ Å»ýÀÇ ¹°¸®ÇÐÀÚ J.B.Gunn ÀÇ À̸§¿¡¼­
  • Raman effect
    ¶ó¸¸ È¿°ú(ºûÀÌ Åõ¸íÇÑ ¸ÅÁúÀ» Åë°úÇÒ ¶§,»ê¶õÇÏ¿© ºûÀÇ ÀϺΠÆÄÀåÀÌ º¯È­ÇÏ´Â Çö»ó)
  • cause-and-effect
    Àΰú °ü°èÀÇ
  • echo effect
    ¸Þ¾Æ¸® È¿°ú(¾î¶² ÀÏÀÌ µÚ´Ê°Ô µÇÇ®ÀÌ µÇ°Å³ª,±× °á°ú°¡ ´Ê°Ô ³ªÅ¸³ª´Â µîÀÇ Çö»ó)
  • effect
    °á°ú;¿µÇâ;È¿°ú;À¯È¿;´À³¦;Àλó;ºû±òÀÇ ¹èÇÕ;ÃëÁö;´ëÀÇ;¿Ü°ü;°á°ú¸¦ °¡Á®¿À´Ù;´Ù;¸ñÀûÀ» ÀÌ·ç´Ù
  • electrooptic effect
    (Àü)Àü±â ±¤ÇÐ È¿°ú
  • glasshouse effect
    =GREENHOUSE EFFECT
  • greenhouse effect
    (ź»ê°¡½º¿¡ ÀÇÇÑ Áö±¸ ´ë±âÀÇ)¿Â½Ç È¿°ú 
  • ground effect machine
    Áö¸é È¿°ú±â;È£¹öÅ©¶óÇÁÆ®
  • halo effect
    Èı¤ÀÇ È¿°ú !
  • hothouse effect
    =greenhouse effect
  • inertia effect
    °ü¼ºÈ¿°ú !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á